Nuveen Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$5.84M Sell
151,197
-80,877
-35% -$3.12M ﹤0.01% 1908
2024
Q3
$10.4M Sell
232,074
-141,918
-38% -$6.39M ﹤0.01% 1574
2024
Q2
$13M Sell
373,992
-304,209
-45% -$10.5M ﹤0.01% 1418
2024
Q1
$19.6M Buy
678,201
+372,782
+122% +$10.8M 0.01% 1194
2023
Q4
$7M Sell
305,419
-230,605
-43% -$5.29M ﹤0.01% 1789
2023
Q3
$8.94M Sell
536,024
-399,937
-43% -$6.67M ﹤0.01% 1544
2023
Q2
$25.9M Buy
935,961
+107,490
+13% +$2.97M 0.01% 912
2023
Q1
$19.1M Buy
828,471
+467,757
+130% +$10.8M 0.01% 1080
2022
Q4
$3.94M Buy
360,714
+22,170
+7% +$242K ﹤0.01% 2052
2022
Q3
$2.85M Buy
338,544
+572
+0.2% +$4.82K ﹤0.01% 2201
2022
Q2
$2.67M Buy
337,972
+33,860
+11% +$268K ﹤0.01% 2290
2022
Q1
$2.35M Buy
304,112
+64,183
+27% +$496K ﹤0.01% 2427
2021
Q4
$1.85M Buy
239,929
+76,843
+47% +$594K ﹤0.01% 2599
2021
Q3
$1.26M Sell
163,086
-3,239
-2% -$25K ﹤0.01% 2894
2021
Q2
$1.29M Buy
166,325
+21,625
+15% +$167K ﹤0.01% 2911
2021
Q1
$1.12M Buy
144,700
+32,129
+29% +$248K ﹤0.01% 2853
2020
Q4
$870K Sell
112,571
-726
-0.6% -$5.61K ﹤0.01% 2853
2020
Q3
$876K Buy
113,297
+22,525
+25% +$174K ﹤0.01% 2740
2020
Q2
$701K Sell
90,772
-8,301
-8% -$64.1K ﹤0.01% 2773
2020
Q1
$700K Sell
99,073
-95,364
-49% -$674K ﹤0.01% 2652
2019
Q4
$1.37M Buy
194,437
+43,906
+29% +$309K ﹤0.01% 2578
2019
Q3
$1.81M Buy
150,531
+111,656
+287% +$1.34M ﹤0.01% 2446
2019
Q2
$470K Buy
+38,875
New +$470K ﹤0.01% 3015